Arcus Biosciences, Inc.

RCUS

$29.69

-1.46%

2026-09-04 09:48:01 EDT-$0.44

Healthcare

Biotechnology

NYSE

Active Trading

Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States. The company’s development product portfolio includes ...

Financial Highlights of RCUS

Profitability trend

Latest / TTM · 6 periods

Gross Margin

94.0%

Net Margin

-386.3%

P/E Ratio

-7.63x

n/a

Debt / Equity

0.25

n/a

Current Ratio

3.82

Dividend Yield

0.0%

Understanding

TTM —

Interest coverage is weak

Financial highlights

Latest / TTM · 6 periods

Snapshot

Latest / TTM: 2026-09-03

Gross Margin

94.0%

Net Margin

-386.3%

P/E Ratio

-7.63x

Debt / Equity

0.25

Profitability

Profitability table

Metric	2021	2022	2023	2024	2025	2026
Gross MarginGross profit as a percentage of revenue.	100.0%	100.0%	100.0%	100.0%	96.0%	—
Operating MarginOperating income as a percentage of revenue.	14.1%	-250.0%	-290.6%	-127.9%	-156.3%	—
Net MarginNet income as a percentage of revenue.	13.8%	-238.4%	-262.4%	-109.7%	-142.9%	—
EBITDA MarginEBITDA divided by revenue.	15.4%	-230.4%	-248.7%	-104.3%	-135.6%	—
Pre-tax MarginPre-tax profit as a percentage of revenue.	14.4%	-237.5%	-257.3%	-109.7%	-142.9%	—

Liquidity & leverage

Liquidity & leverage table

Metric	2021	2022	2023	2024	2025	2026
Current RatioCurrent assets divided by current liabilities.	7.60	5.52	4.52	4.50	4.36	—
Quick RatioLiquid assets divided by current liabilities.	7.60	5.52	4.52	4.50	4.36	—
Cash RatioCash and equivalents divided by current liabilities.	0.89	1.07	0.69	0.66	0.96	—
Debt / AssetsDebt as a share of total assets.	7.7%	8.9%	1.0%	5.2%	9.8%	—
Debt / EquityDebt compared with shareholder equity.	0.14	0.18	0.02	0.12	0.18	—

Operating efficiency

Operating efficiency table

Metric	2021	2022	2023	2024	2025	2026
Receivables TurnoverHow often receivables are collected in a year.	0.51x	2.60x	2.79x	10.32x	15.44x	—
Inventory TurnoverHow often inventory is sold in a year.	0.00x	0.00x	0.00x	0.00x	0.00x	—
Payables TurnoverHow often payables are paid in a year.	0.00x	0.00x	0.00x	0.00x	0.24x	—
Asset TurnoverRevenue generated per dollar of assets.	0.24x	0.08x	0.11x	0.22x	0.22x	—
Working Capital TurnoverRevenue generated per dollar of working capital.	0.45x	0.11x	0.15x	0.36x	0.32x	—

Valuation ratios

Valuation ratios table

Metric	2021	2022	2023	2024	2025	2026
P/E RatioPrice paid for each dollar of earnings.	53.25x	-5.57x	-4.60x	-4.74x	-7.24x	—
P/B RatioPrice paid for each dollar of book value.	3.34x	2.27x	3.06x	2.77x	4.06x	—
P/S RatioPrice paid for each dollar of sales.	7.33x	13.29x	12.08x	5.20x	10.36x	—
P/FCF RatioPrice paid for each dollar of free cash flow.	-9.94x	3.45x	-4.28x	-7.62x	-5.29x	—
Dividend YieldAnnual dividend divided by current share price.	0.0%	0.0%	0.0%	0.0%	0.0%	—

About UsPrivacy PolicyTerms of ServiceDisclaimerStock DirectoryETFsIndices13F HoldingsAnalyst TargetsFree ToolsTechnology MapJoin our Slack

Plutux is not an investment adviser. Market data and AI-generated analysis are for information and education only, not investment advice. Disclaimer